U.S., Jan. 29 -- ClinicalTrials.gov registry received information related to the study (NCT06797245) titled 'APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women' on Jan. 22.
Brief Summary: The APPROVE trial is a multi-centered, randomized controlled trial designed to assess differences in symptom improvement, quality of life, bladder symptoms, satisfaction with treatment and continued treatment efficacy in women with overactive bladder (OAB) randomized to a prescription digital therapeutic (PDTx) app called RiSolve compared to standard behavioral education (handouts).
Study Start Date: Feb., 2025
Study Type: INTERVENTIONAL
Condition:
Overactive Bladder (OAB)
Urinary Urgency
Urinary Urge Incontinen...